GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity | 2.82% (2/71) | 8.52 | 1.4e-05 | 0.000999 |
GO:0004749 | ribose phosphate diphosphokinase activity | 2.82% (2/71) | 8.59 | 1.3e-05 | 0.001142 |
GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process | 2.82% (2/71) | 8.59 | 1.3e-05 | 0.001142 |
GO:0046391 | 5-phosphoribose 1-diphosphate metabolic process | 2.82% (2/71) | 8.59 | 1.3e-05 | 0.001142 |
GO:0002189 | ribose phosphate diphosphokinase complex | 2.82% (2/71) | 8.59 | 1.3e-05 | 0.001142 |
GO:0061024 | membrane organization | 5.63% (4/71) | 4.3 | 5.6e-05 | 0.003258 |
GO:0016778 | diphosphotransferase activity | 2.82% (2/71) | 7.33 | 7.5e-05 | 0.003749 |
GO:0030136 | clathrin-coated vesicle | 2.82% (2/71) | 6.67 | 0.000186 | 0.00546 |
GO:0008289 | lipid binding | 5.63% (4/71) | 3.79 | 0.000216 | 0.005861 |
GO:0032050 | clathrin heavy chain binding | 2.82% (2/71) | 6.68 | 0.000184 | 0.005885 |
GO:0015936 | coenzyme A metabolic process | 2.82% (2/71) | 6.48 | 0.000244 | 0.006124 |
GO:0048268 | clathrin coat assembly | 2.82% (2/71) | 6.71 | 0.000177 | 0.006241 |
GO:0005545 | 1-phosphatidylinositol binding | 2.82% (2/71) | 6.71 | 0.000177 | 0.006241 |
GO:0005905 | clathrin-coated pit | 2.82% (2/71) | 6.84 | 0.000148 | 0.006514 |
GO:0098590 | plasma membrane region | 2.82% (2/71) | 6.37 | 0.000283 | 0.006649 |
GO:0000287 | magnesium ion binding | 4.23% (3/71) | 4.5 | 0.000337 | 0.00697 |
GO:0019693 | ribose phosphate metabolic process | 5.63% (4/71) | 3.64 | 0.00032 | 0.007042 |
GO:0072583 | clathrin-dependent endocytosis | 2.82% (2/71) | 6.02 | 0.000454 | 0.008417 |
GO:0006163 | purine nucleotide metabolic process | 5.63% (4/71) | 3.52 | 0.000432 | 0.008443 |
GO:0006900 | vesicle budding from membrane | 2.82% (2/71) | 5.83 | 0.000595 | 0.009527 |
GO:0009123 | nucleoside monophosphate metabolic process | 2.82% (2/71) | 5.49 | 0.000948 | 0.009533 |
GO:0072521 | purine-containing compound metabolic process | 5.63% (4/71) | 3.43 | 0.000545 | 0.009584 |
GO:0016126 | sterol biosynthetic process | 2.82% (2/71) | 5.79 | 0.000632 | 0.009666 |
GO:0006753 | nucleoside phosphate metabolic process | 5.63% (4/71) | 3.26 | 0.000855 | 0.009709 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 2.82% (2/71) | 5.49 | 0.000943 | 0.009762 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.82% (2/71) | 5.58 | 0.000837 | 0.009822 |
GO:0052906 | tRNA (guanine(37)-N1)-methyltransferase activity | 1.41% (1/71) | 10.73 | 0.000591 | 0.0099 |
GO:0031903 | microbody membrane | 2.82% (2/71) | 5.5 | 0.000938 | 0.010005 |
GO:0005778 | peroxisomal membrane | 2.82% (2/71) | 5.5 | 0.000938 | 0.010005 |
GO:0030276 | clathrin binding | 2.82% (2/71) | 5.58 | 0.000832 | 0.010104 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.82% (2/71) | 5.58 | 0.000832 | 0.010104 |
GO:0030135 | coated vesicle | 2.82% (2/71) | 5.71 | 0.000698 | 0.010243 |
GO:0006898 | receptor-mediated endocytosis | 2.82% (2/71) | 5.63 | 0.000782 | 0.010586 |
GO:0004252 | serine-type endopeptidase activity | 4.23% (3/71) | 4.1 | 0.000753 | 0.010609 |
GO:0009117 | nucleotide metabolic process | 5.63% (4/71) | 3.27 | 0.000823 | 0.010735 |
GO:0019637 | organophosphate metabolic process | 7.04% (5/71) | 2.63 | 0.001325 | 0.012954 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 5.63% (4/71) | 3.04 | 0.001464 | 0.01393 |
GO:0031410 | cytoplasmic vesicle | 4.23% (3/71) | 3.67 | 0.001765 | 0.015927 |
GO:0097708 | intracellular vesicle | 4.23% (3/71) | 3.67 | 0.001765 | 0.015927 |
GO:0016405 | CoA-ligase activity | 2.82% (2/71) | 4.99 | 0.001881 | 0.016549 |
GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding | 2.82% (2/71) | 4.8 | 0.002417 | 0.020751 |
GO:0006694 | steroid biosynthetic process | 2.82% (2/71) | 4.73 | 0.002672 | 0.022396 |
GO:0032483 | regulation of Rab protein signal transduction | 1.41% (1/71) | 8.4 | 0.00295 | 0.023073 |
GO:1902936 | phosphatidylinositol bisphosphate binding | 2.82% (2/71) | 4.69 | 0.00283 | 0.023163 |
GO:0002939 | tRNA N1-guanine methylation | 1.41% (1/71) | 8.29 | 0.003185 | 0.023358 |
GO:0009019 | obsolete tRNA (guanine-N1-)-methyltransferase activity | 1.41% (1/71) | 8.29 | 0.003185 | 0.023358 |
GO:0031982 | vesicle | 4.23% (3/71) | 3.41 | 0.002932 | 0.023458 |
GO:1901981 | phosphatidylinositol phosphate binding | 2.82% (2/71) | 4.57 | 0.0033 | 0.023705 |
GO:1901135 | carbohydrate derivative metabolic process | 5.63% (4/71) | 2.69 | 0.003581 | 0.023781 |
GO:0033865 | nucleoside bisphosphate metabolic process | 2.82% (2/71) | 4.46 | 0.003852 | 0.023791 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 2.82% (2/71) | 4.46 | 0.003852 | 0.023791 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 2.82% (2/71) | 4.46 | 0.003852 | 0.023791 |
GO:0016125 | sterol metabolic process | 2.82% (2/71) | 4.61 | 0.003122 | 0.023888 |
GO:0006897 | endocytosis | 2.82% (2/71) | 4.55 | 0.003409 | 0.023999 |
GO:0017171 | serine hydrolase activity | 4.23% (3/71) | 3.31 | 0.003561 | 0.024104 |
GO:0008236 | serine-type peptidase activity | 4.23% (3/71) | 3.31 | 0.003561 | 0.024104 |
GO:0000149 | SNARE binding | 2.82% (2/71) | 4.47 | 0.003794 | 0.024734 |
GO:0016050 | vesicle organization | 2.82% (2/71) | 4.38 | 0.00426 | 0.025854 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 2.82% (2/71) | 4.28 | 0.004858 | 0.028986 |
GO:0000785 | chromatin | 2.82% (2/71) | 4.25 | 0.005099 | 0.029915 |
GO:0008202 | steroid metabolic process | 2.82% (2/71) | 4.22 | 0.005323 | 0.030715 |
GO:0098657 | import into cell | 2.82% (2/71) | 4.17 | 0.005666 | 0.03217 |
GO:0035091 | phosphatidylinositol binding | 2.82% (2/71) | 4.14 | 0.005877 | 0.032838 |
GO:0019210 | kinase inhibitor activity | 1.41% (1/71) | 7.19 | 0.00683 | 0.037565 |
GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity | 1.41% (1/71) | 7.05 | 0.007534 | 0.040181 |
GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity | 1.41% (1/71) | 7.05 | 0.007534 | 0.040181 |
GO:1901617 | organic hydroxy compound biosynthetic process | 2.82% (2/71) | 3.93 | 0.007839 | 0.040578 |
GO:0009725 | response to hormone | 2.82% (2/71) | 3.93 | 0.007799 | 0.040972 |
GO:0006164 | purine nucleotide biosynthetic process | 2.82% (2/71) | 3.87 | 0.008387 | 0.042785 |
GO:0042579 | microbody | 2.82% (2/71) | 3.85 | 0.008653 | 0.043512 |
GO:0004725 | protein tyrosine phosphatase activity | 1.41% (1/71) | 6.57 | 0.010462 | 0.044908 |
GO:0046578 | regulation of Ras protein signal transduction | 1.41% (1/71) | 6.57 | 0.010462 | 0.044908 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.41% (1/71) | 6.57 | 0.010462 | 0.044908 |
GO:0072522 | purine-containing compound biosynthetic process | 2.82% (2/71) | 3.76 | 0.00971 | 0.044973 |
GO:0009719 | response to endogenous stimulus | 2.82% (2/71) | 3.76 | 0.00971 | 0.044973 |
GO:0052744 | phosphatidylinositol monophosphate phosphatase activity | 1.41% (1/71) | 6.71 | 0.009526 | 0.045311 |
GO:0003994 | aconitate hydratase activity | 1.41% (1/71) | 6.73 | 0.009409 | 0.045368 |
GO:0004175 | endopeptidase activity | 4.23% (3/71) | 2.77 | 0.00993 | 0.045394 |
GO:0006101 | citrate metabolic process | 1.41% (1/71) | 6.74 | 0.009292 | 0.045426 |
GO:0030350 | iron-responsive element binding | 1.41% (1/71) | 6.76 | 0.009174 | 0.045485 |
GO:0008299 | isoprenoid biosynthetic process | 2.82% (2/71) | 3.71 | 0.010374 | 0.046222 |
GO:0046390 | ribose phosphate biosynthetic process | 2.82% (2/71) | 3.72 | 0.010252 | 0.046263 |
GO:0005789 | endoplasmic reticulum membrane | 2.82% (2/71) | 3.62 | 0.011678 | 0.049528 |